Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Donald L. Tankersley"'
Autor:
Miriam J. Alter, Jay H. Hoofnagel, J.S. Finlayson, Harvey J. Alter, Donald L. Tankersley, Stephen M. Feinstone, Bruce L. Evatt, Jay S. Epstein, Robin Biswas, Harold S. Margolis
Publikováno v:
American Journal of Infection Control. 19:32A-41A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36f2f1f5f64e2f981c8c55cf9b195f76
https://doi.org/10.1016/s0196-6553(05)80268-8
https://doi.org/10.1016/s0196-6553(05)80268-8
Autor:
Dorrie A. Carson, George Kuo, Donald L. Tankersley, Emory L. Meeks, Saswati D. Sinha, Krzysztof Krawczynski, Miriam J. Alter, Betty H. Robertson, Michael J. Beach, John Spelbring, Stephen B. Lambert
Publikováno v:
The Journal of infectious diseases. 173(4)
The efficacy of postexposure prophylaxis for the prevention of hepatitis C virus (HCV) infection was studied in experimentally infected chimpanzees. Three chimpanzees were inoculated with HCV: Two were treated 1 h later with anti-HCV--negative intrav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3d8c3443af0e8aedd54c2ad2b33ba63
https://pubmed.ncbi.nlm.nih.gov/8603959
https://pubmed.ncbi.nlm.nih.gov/8603959
Autor:
Donald L. Tankersley
Publikováno v:
Immunological reviews. 139
IgG dimers occurring in therapeutic Ig preparations have been characterized as Id-anti-Id, in that the sites of interaction are localized to the distal tips of the Fab arms. The observation that such dimers are prevalent in Ig or Igi.v. prepared from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec06ea7067bec189b94b5c7a7b6d0cc2
https://pubmed.ncbi.nlm.nih.gov/7927410
https://pubmed.ncbi.nlm.nih.gov/7927410
Autor:
Sayah Nedjar, Leonard Wilson, Robin Biswas, Freddie Mitchell, J.S. Finlayson, Donald L. Tankersley
Publikováno v:
Viral Hepatitis and Liver Disease ISBN: 9784431682578
A study was performed to determine whether the safety of intravenous immunoglobulin (IGIV) would be compromised if units of plasma reactive for antibody to hepatitis C (anti-c100-3) were withheld from pools from which IGIV is manufactured. Initially,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::960658e8181589b9dc137672097d7381
https://doi.org/10.1007/978-4-431-68255-4_151
https://doi.org/10.1007/978-4-431-68255-4_151
Publikováno v:
Viral Hepatitis and Liver Disease ISBN: 9784431682578
The partitioning of hepatitic C virus (HCV) during immune globulin production by cold ethanol fractionation was studied by utilizing a plasma pool comprising 186 anti-c100-3-reactive donations. In addition, various commercial immune globulin preparat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e8cb7193b3934988eb94836d03548b1
https://doi.org/10.1007/978-4-431-68255-4_150
https://doi.org/10.1007/978-4-431-68255-4_150
Publikováno v:
Clinical Therapeutics. 18:71-72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7857154ea550eca0ce8200e84034ed1c
https://doi.org/10.1016/s0149-2918(96)80197-4
https://doi.org/10.1016/s0149-2918(96)80197-4
Autor:
Donald L. Tankersley
Publikováno v:
Vox Sanguinis. 78:132-132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7934e3bb27eeb41d06842e139ebbf503
https://doi.org/10.1046/j.1423-0410.2000.78201303.x
https://doi.org/10.1046/j.1423-0410.2000.78201303.x
Autor:
Thomas K. Hazlet, Donald L. Tankersley
Publikováno v:
American Journal of Health-System Pharmacy. 50:654-654
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf5061d8858255d9a8c88971351cb973
https://doi.org/10.1093/ajhp/50.4.654
https://doi.org/10.1093/ajhp/50.4.654
Publikováno v:
Blood. 62:448-456
A system was developed for studying the activation of factor XII (Hageman factor) in the presence of dextran sulfate (DS). Salient features of the system included low ionic strength (0.08), low concentration of factor XII (approximately 1/10,000 that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2848aaf371cf3980ecdfce6491858dd
https://doi.org/10.1182/blood.v62.2.448.448
https://doi.org/10.1182/blood.v62.2.448.448
Publikováno v:
Thrombosis Research. 25:307-317
beta-Factor XIIa (beta-XIIa, Mr approximately 30,000) was isolated from human plasma by a procedure which utilized, as an initial step, the adsorption of Factor XII to celite. Activation of Factor XII and subsequent release of beta-XIIa was brought a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2021c1aa9ebd3618d5781ae6d24fbbc
https://doi.org/10.1016/0049-3848(82)90231-6
https://doi.org/10.1016/0049-3848(82)90231-6